Eyes On Park Introduces Revolutionary Envision by InMode System for Advanced Dry Eye Treatment in New York City

April 29, 2025 03:41 AM AEST | By News File Corp
 Eyes On Park Introduces Revolutionary Envision by InMode System for Advanced Dry Eye Treatment in New York City
Image source: Kalkine Media

New York, New York--(Newsfile Corp. - April 28, 2025) -  Eyes On Park, a leading optometry practice in Gramercy Park, announces the introduction of the cutting-edge Envision by InMode system for comprehensive dry eye treatment. Dr. Irina Shiyan and her team now offer this advanced, non-invasive technology that combines Forma-I radiofrequency and Lumecca-I intense pulsed light therapies to address the root causes of dry eye disease, not just the symptoms.

Cannot view this image? Visit: https://images.newsfilecorp.com/files/10373/249978_4d88b11e2423a891_001.jpg
Eyes On Park

To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/10373/249978_4d88b11e2423a891_001full.jpg

Dry eye syndrome affects millions of Americans, significantly impacting quality of life and vision, yet often remains undertreated. The Envision by InMode system represents a paradigm shift in dry eye management by targeting inflammation, improving meibomian gland function, and enhancing tear production for lasting relief without relying on constant medication use.

"We're excited to bring this revolutionary technology to our patients in New York City," said Dr. Irina Shiyan, lead optometrist at Eyes On Park. "The Envision system allows us to treat the underlying causes of dry eye disease with precision and effectiveness not previously possible with conventional treatments. Most patients experience noticeable improvement after just one session."

Dual Treatment Modalities for Comprehensive Care

The Envision by InMode system features two complementary technologies that work together to address multiple aspects of dry eye disease simultaneously:

Forma-I Radiofrequency (RF) Technology

Forma-I delivers bipolar radiofrequency energy to the delicate subdermal layers around the eyes. This precision RF depth control technology gently heats the tissue, creating a sensation similar to a warm massage while improving blood circulation and stimulating natural healing processes.

The Forma-I treatment provides multiple therapeutic benefits:

  • Stimulates collagen production in the eyelid tissues
  • Improves blood flow to the meibomian glands
  • Opens clogged meibomian glands for better oil secretion
  • Attracts white blood cells and stem cells to reduce inflammation

The system's intelligent temperature monitoring ensures safe treatment of the small and delicate areas around the eyes. Forma-I is particularly effective for meibomian gland dysfunction, where inadequate oil production leads to tear evaporation and dry eye symptoms.

Lumecca-I Intense Pulsed Light (IPL) Therapy

Lumecca-I delivers powerful, intense pulsed light therapy specifically designed for the eye area. During treatment, brief pulses of light create tissue heating that helps reduce inflammation. Patients typically feel a light snap with each pulse, similar to an elastic band.

The benefits of this advanced treatment include:

  • Reducing inflammatory markers in the eyelid and tear film
  • Decreasing demodex and bacteria around the eyelids
  • Closing off blood vessels that release inflammatory factors
  • Treating pigmented and vascular lesions associated with ocular rosacea

Many patients with inflammatory dry eye and ocular rosacea experience significant improvement after Lumecca-I treatments. Any redness or slight warming of the skin typically subsides within an hour.

Enhanced Treatment with Meibomian Gland Expression

Following Forma-I radiofrequency treatment, Eyes On Park often performs meibomian gland expression to maximize benefits. This procedure helps clear blockages in the meibomian glands, allowing them to release oils essential for a stable tear film. The treatment involves applying gentle pressure to the eyelids after RF treatment has warmed and softened the oil, making expression more comfortable and effective.

This technique helps:

  • Clear blockages in the oil-producing glands
  • Restore proper oil flow into the tear film
  • Prevent further gland damage
  • Improve tear quality and reduce evaporation

This hands-on approach complements the technological treatments of the Envision system for comprehensive dry eye management.

Personalized Treatment Plans Based on Advanced Diagnostics

Treatment plans at Eyes On Park are customized based on comprehensive diagnostic testing, including advanced K5M diagnostic scans of the tear film and meibomian glands. This detailed analysis allows Dr. Shiyan to develop highly personalized treatment protocols for each patient.

"No two cases of dry eye disease are identical," explained Dr. Shiyan. "Our diagnostic capabilities allow us to precisely identify the underlying causes of each patient's symptoms and tailor a treatment plan using the Envision system that addresses their specific needs. This targeted approach leads to better outcomes and higher patient satisfaction."

Customized treatment plans may include:

  • A specific sequence of Forma-I and Lumecca-I treatments
  • Recommended frequency based on condition severity
  • Meibomian gland expression techniques
  • Complementary home care recommendations

Non-Invasive Treatment with No Downtime

The Envision treatments are non-invasive procedures that require no downtime, allowing patients to return to their normal activities immediately after each session. Most patients experience noticeable improvement after just one treatment, with optimal results typically achieved after a series of sessions.

Unlike traditional dry eye treatments that focus primarily on symptom management through artificial tears or medications, the Envision system addresses the underlying causes of dry eye disease for more sustainable relief. This approach reduces dependence on constant medication use and provides longer-lasting results.

Availability and Consultation Information

The Envision by InMode system is now available at Eyes On Park in Gramercy Park, New York City. Patients interested in learning if this advanced dry eye treatment is right for them can schedule a consultation by calling 332-208-7849 or booking an appointment online.

During the consultation, Dr. Shiyan conducts a comprehensive dry eye evaluation to determine the specific causes of the patient's symptoms and develop a personalized treatment plan using the Envision system.

About Eyes On Park

Eyes On Park is a premier optometry practice located in Gramercy Park, New York City. Led by Dr. Irina Shiyan, the practice is committed to providing exceptional eye care using the latest technologies and treatment approaches. The team specializes in comprehensive eye exams, contact lens fittings, and advanced treatments for various eye conditions, including dry eye disease.

Media Contact

For more information about the Envision by InMode system or to schedule an interview with Dr. Irina Shiyan, please contact:

###

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/249978


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.